Inspire Medical Systems, Inc. Basic Shares Outstanding (Weighted Average)
Inspire Medical Systems, Inc. (INSP) reported Basic Shares Outstanding (Weighted Average) of 28.84 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-03
- Inspire Medical Systems, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 28.84M shares, a 2.28% decline year-over-year.
- Inspire Medical Systems, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 28.70M shares, a 3.37% decline year-over-year.
- Inspire Medical Systems, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 28.94M shares, a 2.98% decline year-over-year.
- Inspire Medical Systems, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 29.33M shares, a 1.83% decline year-over-year.
- Inspire Medical Systems, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 29.37M shares, a 1.33% decline from fiscal 2024.
- Inspire Medical Systems, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 29.76M shares, a 1.57% increase from fiscal 2023.
- Inspire Medical Systems, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 29.30M shares, a 4.38% increase from fiscal 2022.
- Inspire Medical Systems, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 28.07M shares, a 2.97% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 28.84M shares 10-Q · filed 2026-08-03 | 28.77M shares 10-Q · filed 2026-08-03 | 28.82M shares derived: average of 3 quarters · filed 2026-08-03 | 28.95M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | 28.70M shares 10-Q · filed 2026-05-04 | 28.82M shares derived: average of 2 quarters · filed 2026-05-04 | 28.99M shares derived: average of 3 quarters · filed 2026-05-04 | 29.12M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | 28.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 29.14M shares derived: average of 2 quarters · filed 2026-02-13 | 29.26M shares derived: average of 3 quarters · filed 2026-08-03 | 29.37M shares 10-K · filed 2026-02-13 |
| 2025-09-30 | 29.33M shares 10-Q · filed 2025-11-03 | 29.42M shares derived: average of 2 quarters · filed 2026-08-03 | 29.51M shares 10-Q · filed 2025-11-03 | 29.59M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | 29.51M shares 10-Q · filed 2026-08-03 | 29.60M shares 10-Q · filed 2026-08-03 | 29.68M shares derived: average of 3 quarters · filed 2026-08-03 | 29.73M shares derived: average of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | 29.70M shares 10-Q · filed 2026-05-04 | 29.77M shares derived: average of 2 quarters · filed 2026-05-04 | 29.80M shares derived: average of 3 quarters · filed 2026-05-04 | 29.78M shares derived: average of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | 29.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 29.85M shares derived: average of 2 quarters · filed 2026-02-13 | 29.81M shares derived: average of 3 quarters · filed 2026-02-13 | 29.76M shares 10-K · filed 2026-02-13 |
| 2024-09-30 | 29.88M shares 10-Q · filed 2025-11-03 | 29.80M shares derived: average of 2 quarters · filed 2025-11-03 | 29.74M shares 10-Q · filed 2025-11-03 | 29.69M shares derived: average of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | 29.73M shares 10-Q · filed 2025-08-04 | 29.67M shares 10-Q · filed 2025-08-04 | 29.62M shares derived: average of 3 quarters · filed 2026-02-13 | 29.56M shares derived: average of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | 29.62M shares 10-Q · filed 2025-05-05 | 29.57M shares derived: average of 2 quarters · filed 2026-02-13 | 29.50M shares derived: average of 3 quarters · filed 2026-02-13 | 29.43M shares derived: average of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | 29.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 29.44M shares derived: average of 2 quarters · filed 2026-02-13 | 29.37M shares derived: average of 3 quarters · filed 2026-02-13 | 29.30M shares 10-K · filed 2026-02-13 |
| 2023-09-30 | 29.37M shares 10-Q · filed 2024-11-04 | 29.30M shares derived: average of 2 quarters · filed 2024-11-04 | 29.23M shares 10-Q · filed 2024-11-04 | 29.16M shares derived: average of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | 29.23M shares 10-Q · filed 2024-08-06 | 29.16M shares 10-Q · filed 2024-08-06 | 29.09M shares derived: average of 3 quarters · filed 2025-02-10 | 28.87M shares derived: average of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | 29.09M shares 10-Q · filed 2024-05-07 | 29.02M shares derived: average of 2 quarters · filed 2025-02-10 | 28.75M shares derived: average of 3 quarters · filed 2025-02-10 | 28.46M shares derived: average of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | 28.94M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | 28.58M shares derived: average of 2 quarters · filed 2025-02-10 | 28.25M shares derived: average of 3 quarters · filed 2025-02-10 | 28.07M shares 10-K · filed 2025-02-10 |
| 2022-09-30 | 28.23M shares 10-Q · filed 2023-11-07 | 27.91M shares derived: average of 2 quarters · filed 2023-11-07 | 27.78M shares 10-Q · filed 2023-11-07 | 27.68M shares derived: average of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | 27.59M shares 10-Q · filed 2023-08-01 | 27.56M shares 10-Q · filed 2023-08-01 | 27.50M shares derived: average of 3 quarters · filed 2024-02-09 | 27.45M shares derived: average of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | 27.52M shares 10-Q · filed 2023-05-02 | 27.45M shares derived: average of 2 quarters · filed 2024-02-09 | 27.40M shares derived: average of 3 quarters · filed 2024-02-09 | 27.36M shares derived: average of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | 27.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | 27.34M shares derived: average of 2 quarters · filed 2024-02-09 | 27.30M shares derived: average of 3 quarters · filed 2024-02-09 | 27.26M shares 10-K · filed 2024-02-09 |
| 2021-09-30 | 27.30M shares 10-Q · filed 2022-11-01 | 27.27M shares derived: average of 2 quarters · filed 2022-11-01 | 27.23M shares 10-Q · filed 2022-11-01 | 27.17M shares derived: average of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | 27.23M shares 10-Q · filed 2022-08-02 | 27.19M shares 10-Q · filed 2022-08-02 | 27.12M shares derived: average of 3 quarters · filed 2023-02-10 | 27.05M shares derived: average of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | 27.14M shares 10-Q · filed 2022-05-03 | 27.07M shares derived: average of 2 quarters · filed 2023-02-10 | 26.99M shares derived: average of 3 quarters · filed 2023-02-10 | 26.82M shares derived: average of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | 26.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | 26.91M shares derived: average of 2 quarters · filed 2023-02-10 | 26.71M shares derived: average of 3 quarters · filed 2023-02-10 | 26.07M shares 10-K · filed 2023-02-10 |
| 2020-09-30 | 26.84M shares 10-Q · filed 2021-11-02 | 26.56M shares derived: average of 2 quarters · filed 2021-11-02 | 25.77M shares 10-Q · filed 2021-11-02 | |
| 2020-06-30 | 26.29M shares 10-Q · filed 2021-08-03 | 25.23M shares 10-Q · filed 2021-08-03 | ||
| 2019-12-31 | 23.80M shares 10-K · filed 2022-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |